Large-scale proteomic identification of S100 proteins in breast cancer tissues

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Cancemi, Patrizia ^a,c   Di Cara, Gianluca ^a   Albanese, Nadia N ^a   Costantini, Francesca ^a   Marabeti, Maria R ^a   Musso, Rosa ^a   Lupo, Carmelo ^b   Roz, Elena ^b   Pucci Minafra, Ida ^a,c  

^a UNIVERSITY OF PALERMO   (Italy)

^b LA MADDALENA CANCER CENTER   (Italy)

^c Centro di OncoBiologia Sperimentale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CALCYCLIN; CALGIZZARIN; CALGRANULIN A; CALVASCULIN; PROTEIN S 100; PROTEIN S 100A2; PSORIASIN; S100 CALCIUM BINDING PROTEIN A13; UNCLASSIFIED DRUG; PROTEOME; TUMOR MARKER;

ADULT; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER TISSUE; CHROMOSOME 1; CONTROLLED STUDY; CRYOPRESERVATION; DISTANT METASTASIS; FOLLOW UP; FUNCTIONAL PROTEOMICS; GENE CLUSTER; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; PEPTIDE MASS FINGER PRINTING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; UPREGULATION; BREAST; BREAST TUMOR; COHORT ANALYSIS; FEMALE; MASS SPECTROMETRY; METABOLISM; METASTASIS; PATHOLOGY; PROGNOSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; COHORT STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; NEOPLASM METASTASIS; PROGNOSIS; PROTEOME; S100 PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 77956482062     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-476     Document Type: Article

References (35)

1. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965, 19:739-744. 10.1016/0006-291X(65)90320-7, 4953930.
2. Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. Calcium-dependent and -independent interactions of the S100 protein family. Biochem J 2006, 396:201-214. 10.1042/BJ20060195, 1462724, 16683912.
3. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999, 1450:191-231. 10.1016/S0167-4889(99)00058-0, 10395934.
4. Donato R. Intracellular and extracellular roles of S100proteins. Microsc Res Tech 2003, 6:540-51.
5. Donato R. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001, 33:637-68. 10.1016/S1357-2725(01)00046-2, 11390274.
6. Heizmann CW, Fritz G, Schafer BW. S100 proteins: Structure, functions and pathology. Front Biosci 2002, 7:1356-68.
7. Leclerc E, Fritz G, Vetter SW, Heizmann CW. Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 2009, 1793:993-1007. 10.1016/j.bbamcr.2008.11.016, 19121341.
8. Salama I, Malone PS, Mihaimeed F, Jones JL. A review of the S100 proteins in cancer. Eur J Surg Oncol 2008, 34:357-64.
9. Zhang H, Zhao Q, Chen Y, Wang Y, Gao S, Mao Y, Li M, Peng A, He D, Xiao X. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax 2008, 63:352-9. 10.1136/thx.2007.087015, 18364444.
10. Wang G, Wang X, Wang S, Song H, Sun H, Yuan W, Cao B, Bai J, Fu S. Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues. Int J Colorectal Dis 2008, 23:675-82. 10.1007/s00384-008-0464-6, 18340452.
11. Yang YQ, Zhang LJ, Dong H, Jiang CL, Zhu ZG, Wu JX, Wu YL, Han JS, Xiao HS, Gao HJ, Zhang QH. Upregulated expression of S100A6 in human gastric cancer. J Dig Dis 2007, 8:186-93. 10.1111/j.1751-2980.2007.00311.x, 17970874.
12. Ohuchida K, Mizumoto K, Miyasaka Y, Yu J, Cui L, Yamaguchi H, Toma H, Takahata S, Sato N, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. J Pathol 2007, 213:275-82. 10.1002/path.2250, 17940995.
13. Yao R, Davidson DD, Lopez-Beltran A, MacLennan GT, Montironi R, Cheng L. The S100 proteins for screening and prognostic grading of bladder cancer. Histol Histopathol 2007, 22:1025-32.
14. Ohuchida K, Mizumoto K, Yu J, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples. Cancer Epidemiol Biomarkers Prev 2007, 16:649-54. 10.1158/1055-9965.EPI-06-0157, 17416753.
15. Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M, Gläser R. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 2007, 133:253-61. 10.1007/s00432-006-0164-y, 17136347.
16. Kennedy RD, Gorski JJ, Quinn JE, Stewart GE, James CR, Moore S, Mulligan K, Emberley ED, Lioe TF, Morrison PJ, Mullan PB, Reid G, Johnston PG, Watson PH, Harkin DP. BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. Cancer Res 2005, 65:10265-72. 10.1158/0008-5472.CAN-05-1841, 16288014.
17. Emberley ED, Niu Y, Curtis L, Troup S, Mandal SK, Myers JN, Gibson SB, Murphy LC, Watson PH. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer. Cancer Res 2005, 65:5696-702. 10.1158/0008-5472.CAN-04-3927, 15994944.
18. van Dieck J, Fernandez-Fernandez MR, Veprintsev DB, Fersht AR. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers. J Biol Chem 2009, 284:13804-11. 10.1074/jbc.M901351200, 2679481, 19297317.
19. Słomnicki T, Nawrot B, Leśniak W. S100A6 binds p53 and affects its activity. Int J Biochem Cell Biol 2009, 41:784-90. 10.1016/j.biocel.2008.08.007, 18765292.
20. Fernandez-Fernandez MR, Rutherford TJ, Fersht AR. Members of the S100 family bind p53 in two distinct ways. Protein Sci 2008, 17:1663-70. 10.1110/ps.035527.108, 2548378, 18694925.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 7:248-254.
22. Pucci-Minafra I, Fontana S, Cancemi P, Alaimo G, Minafra S. Proteomic patterns of cultured breast cancer cells and epithelial mammary cells. Ann N Y Acad Sci 2002, 963:122-39. 10.1111/j.1749-6632.2002.tb04103.x, 12095937.
23. Pucci-Minafra I, Fontana S, Cancemi P, Basiricò L, Caricato S, Minafra S. A contribution to breast cancer cell proteomics: detection of new sequences. Proteomics 2002, 2:919-27. 10.1002/1615-9861(200207)2:7<919::AID-PROT919>3.0.CO;2-P, 12124937.
24. Pucci-Minafra I, Cancemi P, Albanese NN, Di Cara G, Marabeti MR, Marrazzo A, Minafra S. New protein clustering of breast cancer tissue proteomics using actin content as a cellularity indicator. J Proteome Res 2008, 7:1412-8. 10.1021/pr700748m, 18284189.
25. Wang H, Zhang Z, Li R, Ang KK, Zhang H, Caraway NP, Katz RL, Jiang F. Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer. Int J Cancer 2005, 116:285-90. 10.1002/ijc.21035, 15800916.
26. Semov A, Moreno MJ, Onichtchenko A, Abulrob A, Ball M, Ekiel I, Pietrzynski G, Stanimirovic D, Alakhov V. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 2005, 280:20833-41. 10.1074/jbc.M412653200, 15788416.
27. El-Rifai W, Moskaluk CA, Abdrabbo MK, Harper J, Yoshida C, Riggins GJ, Frierson HF, Powell SM. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 2002, 62:6823-6.
28. Wang G, Zhang S, Fernig DG, Martin-Fernandez M, Rudland PS, Barraclough R. Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes. Oncogene 2005, 24:1445-54. 10.1038/sj.onc.1208291, 15608682.
29. Sedaghat F, Notopoulos A. S100 protein family and its application in clinical practice. Hippokratia 2008, 12:198-204. 2580040, 19158963.
30. Cross SS, Hamdy FC, Deloulme JC, Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005, 46:256-69. 10.1111/j.1365-2559.2005.02097.x, 15720411.
31. Hsieh HL, Schafer BW, Sasaki N, Heizmann CW. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem Biophys Res Commun 2003, 307:375-381. 10.1016/S0006-291X(03)01190-2, 12859967.
32. Jassem E, Serkies K, Dziadziuszko R, Drozdowska A, Kobierska-Gulida G, Skokowski J, Góźdź S, Urbaniak A, Sygut J, Jassem J. Prognostic value of S-100 immunostaining in tumour cells of non-small cell lung cancer. Biomarkers 2006, 11:262-9. 10.1080/13547500600652277, 16760135.
33. Ohuchida K, Mizumoto K, Ishikawa N, Fujii K, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res 2005, 11:7785-93. 10.1158/1078-0432.CCR-05-0714, 16278400.
34. Ohuchida K, Mizumoto K, Ohhashi S, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis. Clin Cancer Res 2006, 12:5417-22. 10.1158/1078-0432.CCR-06-0222, 17000675.
35. Boye K, Maelandsmo GM. S100A4 and metastasis: a small actor playing many roles. Am J Pathol 2010, 176:528-35. 10.2353/ajpath.2010.090526, 20019188.